Cancer News and Research

Latest Cancer News and Research

Multi-disciplinary team awarded grant to develop interdisciplinary oncology palliative care education program

A multi-disciplinary team representing the schools of Medicine, Nursing and Social Work at the University of Louisville, as well as clinical pastoral education programs in three Louisville hospitals, has been awarded a grant of $1,518,092 from the National Institutes of Health that will fund the development, implementation and evaluation of an interdisciplinary oncology palliative care education program. Work related to the project will begin immediately.

9 Sep 2010

Scientists discover sensor in dendritic cells that recognizes HIV

Dendritic cells are the grand sentinels of the immune system, standing guard 24/7 to detect foreign invaders such as viruses and bacteria, and bring news of the invasion to other immune cells to marshal an attack. These sentinels, however, nearly always fail to respond adequately to HIV, the virus causing AIDS. Now a team of scientists at NYU Langone Medical Center has discovered a sensor in dendritic cells that recognizes HIV, spurring a more potent immune response by the sentinels to the virus.

9 Sep 2010

DARA BioSciences presents KRN5500 study results at World Congress on Pain

DARA BioSciences announced today that it presented study results from its Phase 2 multicenter, placebo controlled, double-blind, randomized dose escalation study for KRN5500 at the 13th World Congress on Pain held recently in Montreal.

9 Sep 2010

Quercetin and ferulic acid antioxidants aggravate kidney cancer in severely diabetic rats

Scientists are calling for more research on the possibility that some supposedly healthful plant-based antioxidants - including those renowned for their apparent ability to prevent cancer - may actually aggravate or even cause cancer in some individuals. Their recommendation follows a study in which two such antioxidants - quercetin and ferulic acid - appeared to aggravate kidney cancer in severely diabetic laboratory rats. The study appears in ACS' bi-weekly Journal of Agricultural and Food Chemistry.

9 Sep 2010

NIH awards $6.5M for pharmacogenomics study of key mood-stabilizing drug for bipolar disorder

An international team, led by University of California, San Diego School of Medicine researchers, has been awarded a $6.5 million grant from the National Institutes of Health (NIH) to study the pharmacogenomics of a key mood-stabilizing drug used to treat bipolar disorder.

9 Sep 2010

Scientists develop new strategy for quicker detection of biomarkers that indicate disease

Scientists at the UK's National Physical Laboratory have developed a new strategy for quicker and more precise detection of biomarkers - proteins which indicate disease. The work could pave the way for new tools to detect early stages of Alzheimer's and cancer at the molecular level.

9 Sep 2010

IMF and CHPF join to promote awareness of myeloma in China

The International Myeloma Foundation (IMF), the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today announced plans to sign a cooperative agreement with the Chinese Health Promotion Foundation (CHPF), an agency that operates under the Chinese Ministry of Health, to promote awareness of myeloma in China and to encourage measures to prevent and combat the disease.

9 Sep 2010

AACR, Pancreatic Cancer Action Network accept applications for 2011 research grants program

The American Association for Cancer Research in partnership with the Pancreatic Cancer Action Network is now accepting applications for the 2011 research grants program. The program is administered using the AACR's rigorous peer-review system to ensure that the highest quality science is supported.

9 Sep 2010

US Oncology selects PatientPoint's self-service solutions to enhance patient experience

PatientPoint, a provider of multi-channel self-service applications for the healthcare industry, today announced that US Oncology, the leading integrated oncology company supporting more than 1,300 affiliated physicians in 500 locations throughout 39 states, has selected PatientPoint solutions to provide self-service technologies to enhance the patient experience.

9 Sep 2010

Aflibercept Phase 3 VELOUR clinical trial for mCRC to continue to completion

Sanofi-aventis and Regeneron Pharmaceuticals, Inc. announced that the Phase 3 VELOUR clinical trial of aflibercept (VEGF Trap) in patients with metastatic colorectal cancer (mCRC) will continue to completion as planned, with no modifications due to efficacy or safety concerns. This decision is based on the recommendation of an Independent Data Monitoring Committee (IDMC) following a planned interim analysis.

9 Sep 2010

Hormone treatment with chemotherapy results in deadly side-effect in neuroblastoma children

Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect, according to a major international study published today (Tuesday) in the Journal of Clinical Oncology.

9 Sep 2010

Two genes linked to ovarian clear cell carcinoma

Scientists at the Johns Hopkins Kimmel Cancer Center have identified two genes whose mutations appear to be linked to ovarian clear cell carcinoma, one of the most aggressive forms of ovarian cancer. Clear cell carcinoma is generally resistant to standard therapy.

9 Sep 2010

Zebrafish DCs discovery provide researchers to investigate mammalian immune system

Scientists from the University of California, San Diego School of Medicine have identified dendritic antigen presenting cells in zebrafish, opening the possibility that the tiny fish could become a new model for studying the complexities of the human immune system.

9 Sep 2010

Professional painters face higher risk of developing bladder cancer

A new study by the International Agency for Research on Cancer (IARC) has provided further evidence that professional painters may face a higher risk of developing bladder cancer than the general population.

9 Sep 2010

Researchers find increase in death risk among childhood cancer survivors

Childhood cancer survivors may have an increased risk of death from other forms of cancer, cardiac and cerebrovascular causes more than 25 years after their initial illness, UK scientists have found.

9 Sep 2010

Cleaning products do not increase risk of breast cancer: Research

Results of a new US study published today have looked at whether cleaning products are linked to an increased risk of breast cancer. They appear to show that women who say they used such products in the past are more likely to have breast cancer. But Cancer Research UK said that the results do not prove a link between cleaning products and breast cancer, and that the findings may have been distorted as a result of patients' existing beliefs about the health risks of chemicals.

9 Sep 2010

BC gynecologists initiate campaign to reduce ovarian cancer mortality

Gynecologic oncologists with the Ovarian Cancer Research Program at Vancouver General Hospital (VGH) and the BC Cancer Agency have begun an important campaign that will reduce deaths from ovarian cancer.

9 Sep 2010

Cachexia reduces function and changes muscle structure of heart in mice with colon cancer

The wasting disease associated with some cancers that is typically seen affecting skeletal muscles can also cause significant damage to the heart, new research in mice suggests.

9 Sep 2010

Scientists identify molecular marker to analyze chemotherapy response in breast cancer patients

A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists. The study, part-funded by Cancer Research UK and published in the British Journal of Cancer today (Wednesday), shows for the first time how this molecular marker has been singled out as an independent factor in examining a breast cancer patient's tumour.

9 Sep 2010

Lactic acid fermentation reduces acrylamide formation during production of potatoes and coffee

A small research-based Norwegian company has developed a method to reduce the formation of the carcinogenic compound acrylamide during industrial production of potatoes and coffee. International food giants are paying attention.

9 Sep 2010

Cancer News and Research

Latest Cancer News and Research

Multi-disciplinary team awarded grant to develop interdisciplinary oncology palliative care education program

Scientists discover sensor in dendritic cells that recognizes HIV

DARA BioSciences presents KRN5500 study results at World Congress on Pain

Quercetin and ferulic acid antioxidants aggravate kidney cancer in severely diabetic rats

NIH awards $6.5M for pharmacogenomics study of key mood-stabilizing drug for bipolar disorder

Scientists develop new strategy for quicker detection of biomarkers that indicate disease

IMF and CHPF join to promote awareness of myeloma in China

AACR, Pancreatic Cancer Action Network accept applications for 2011 research grants program

US Oncology selects PatientPoint's self-service solutions to enhance patient experience

Aflibercept Phase 3 VELOUR clinical trial for mCRC to continue to completion

Hormone treatment with chemotherapy results in deadly side-effect in neuroblastoma children

Two genes linked to ovarian clear cell carcinoma

Zebrafish DCs discovery provide researchers to investigate mammalian immune system

Professional painters face higher risk of developing bladder cancer

Researchers find increase in death risk among childhood cancer survivors

Cleaning products do not increase risk of breast cancer: Research

BC gynecologists initiate campaign to reduce ovarian cancer mortality

Cachexia reduces function and changes muscle structure of heart in mice with colon cancer

Scientists identify molecular marker to analyze chemotherapy response in breast cancer patients

Lactic acid fermentation reduces acrylamide formation during production of potatoes and coffee

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in